quantisnow
FeedTopReportsPricing
⌘K
Live feed
00:15:04·354d
SECFiling
Vincerx Pharma Inc. logo

SEC Form EFFECT filed by Vincerx Pharma Inc.

VINC· Vincerx Pharma Inc.
Health Care
Original source

Companies

  • VINC
    Vincerx Pharma Inc.
    Health Care

Recent analyst ratings

  • Jan 14UpdateHC Wainwright & Co.$25.00
  • Dec 23UpdateCantor Fitzgerald$25.00
  • Nov 1UpdateSVB Leerink$24.00
  • Sep 13UpdateLaidlaw$30.00
  • Aug 25UpdateB. Riley Securities$26.00
  • Aug 13UpdateChardan Capital$30.00

Related

  • SEC268d
    Amendment: SEC Form SCHEDULE 13G/A filed by Vincerx Pharma Inc.
  • SEC281d
    SEC Form DEFA14A filed by Vincerx Pharma Inc.
  • PR281d
    Vincerx Pharma, Inc. Announces Additional Adjournment of Special Meeting - Urges Stockholders to Vote FOR Approval of Dissolution Proposal
  • SEC290d
    SEC Form DEFA14A filed by Vincerx Pharma Inc.
  • SEC290d
    SEC Form 8-K filed by Vincerx Pharma Inc.
  • PR290d
    Vincerx Pharma, Inc. Urges Stockholders to Vote FOR Approval of Dissolution Proposal and Announces Potential Range for Distributions to Stockholders
  • SEC309d
    SEC Form DEFA14A filed by Vincerx Pharma Inc.
  • PR309d
    Vincerx Pharma, Inc. Announces Adjournment of Special Meeting - Will Reconvene Meeting on July 16, 2025 to Secure Votes Needed to Approve Dissolution Proposal
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022